AIM
GILD icon

Adapt Investment Managers’s Gilead Sciences GILD Stock Holding History

Adapt Investment Managers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.85M Sell
38,365
-24,800
-39% -$3.27M 0.04% 117
2026
Q1 		$8.8M Buy
+63,165
New +$8.85M 0.12% 102

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Adapt Investment Managers's GILD Position: Q2 2026 in Review

Adapt Investment Managers reduced its Gilead Sciences (GILD) stake by 39% in Q2 2026, selling an estimated $3.27M and leaving 38,365 shares worth $4.85M. The position accounts for 0.04% of the portfolio, ranked #117.

Adapt Investment Managers first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $8.8M in Q1 2026. 756 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Adapt Investment Managers held 38,365 shares of Gilead Sciences worth $4.85M as of Q2 2026.
  • Adapt Investment Managers sold 24,800 Gilead Sciences shares in Q2 2026, an estimated $3.27M.
  • Gilead Sciences made up 0.04% of Adapt Investment Managers's portfolio in Q2 2026, its #117 holding.
  • Adapt Investment Managers first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • Adapt Investment Managers's Gilead Sciences position peaked at $8.8M in Q1 2026.
  • 756 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Adapt Investment Managers's 13F filing for Q2 2026, filed 27 Jul 2026.